<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03807869</url>
  </required_header>
  <id_info>
    <org_study_id>1772</org_study_id>
    <nct_id>NCT03807869</nct_id>
  </id_info>
  <brief_title>Reduction of Intraocular Pressure After I-stent By-pass Implantation in Eyes With Open Angle Glaucoma</brief_title>
  <official_title>Efficacy and Safety of I-stent By-pass Implantation in Eyes With Open Angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Bialystok</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Bialystok</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of this study is to exam the hypotensive effectiveness of I-stent implantation
      depended on number of antiglaucoma eye drops at baseline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The scientific aim of the project is to estimate the average reduction of intraocular
      pressure (IOP) in relation to the initial number of antiglaucoma drops at the end of 12
      months observation period. The subject must suffer from glaucoma and cataract at the same
      time, and qualify for a cataract surgery. The group will be composed of 40 patients of the
      Ophthalmology Clinic of the Medical University of Białystok qualified for planned cataract
      removal surgery. They will be surgically implanted an I-stent by-pass during
      phacoemulsification.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Actual">February 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IntraOcular Pressure measurement (IOP)</measure>
    <time_frame>baseline, 12 months</time_frame>
    <description>change in the level of intraocular pressure measured with Goldmann applanation tonometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Best Corrected Visual Acuity measurement (BCVA)</measure>
    <time_frame>baseline, 12 months</time_frame>
    <description>change in best corrected visual acuity measured with Snellen charts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of antiglaucoma medicines</measure>
    <time_frame>baseline, 12 months</time_frame>
    <description>change in number of antiglaucoma medicines used before and after surgery</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>coexisting glaucoma and cataract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with coexisting glaucoma and cataract qualified to combined glaucoma surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>combined glaucoma surgery</intervention_name>
    <description>phacoemulsification of cataract and I-stent by-pass implantation</description>
    <arm_group_label>coexisting glaucoma and cataract</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  co-existing glaucoma and cataract (NC1, NC2) classified by means of the LOCS III scale
             (Lens Opacity Classification System III)

          -  patients with primary open-angle glaucoma (POAG), pseudoexfoliative glaucoma (PGX) and
             normal tension glaucoma (NTG), with topical hypotensive treatment

          -  written consent to involvement and participation in the study for a period of at least
             12 months was obtained from all patients after they had first been informed of the
             nature of the procedure and other surgical alternatives

        Exclusion Criteria:

          -  no consent to participation in the study

          -  prior surgical and laser procedures in the area of the eye

          -  narrow- or closed-angle glaucoma

          -  post-inflammatory or post-traumatic secondary glaucoma

          -  chronic illness of the cornea or optic nerve

          -  advanced macular degeneration

          -  active inflammatory process

          -  pregnancy

          -  systemic steroid therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zofia Mariak, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of Bialystok</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University</name>
      <address>
        <city>Białystok</city>
        <zip>15-089</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Myers JS, Masood I, Hornbeak DM, Belda JI, Auffarth G, Jünemann A, Giamporcaro JE, Martinez-de-la-Casa JM, Ahmed IIK, Voskanyan L, Katz LJ. Prospective Evaluation of Two iStent(®) Trabecular Stents, One iStent Supra(®) Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes. Adv Ther. 2018 Mar;35(3):395-407. doi: 10.1007/s12325-018-0666-4. Epub 2018 Feb 23.</citation>
    <PMID>29476443</PMID>
  </reference>
  <results_reference>
    <citation>Chansangpetch S, Lau K, Perez CI, Nguyen N, Porco TC, Lin SC. Efficacy of Cataract Surgery With Trabecular Microbypass Stent Implantation in Combined-Mechanism Angle Closure Glaucoma Patients. Am J Ophthalmol. 2018 Nov;195:191-198. doi: 10.1016/j.ajo.2018.08.003. Epub 2018 Aug 8.</citation>
    <PMID>30098352</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 15, 2019</study_first_submitted>
  <study_first_submitted_qc>January 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2019</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>I-stent</keyword>
  <keyword>glaucoma surgery</keyword>
  <keyword>minimally invasive glaucoma surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified individual participant data for all primary and secondary outcome measures will be made available</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data will be available within 6 months of study completion</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the Chair Person. Requestors will be required to sign a Data Access Agreement</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

